RxDoctor Payments Data

Usman Zahir, MD

Orthopaedic Surgery of the Spine · York, PANPI 1346464740

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,475 of the $54,868 with a category attached, or 64.7%. Joimax, Inc. accounts for 66.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $23,039 and has fallen 99.4% since, to $127 in 2025.

$54,868in general payments, 2019–2025

Across 79 payments — averaging $694.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Joimax, Inc.$36K
  • Integrity Implants Inc.$16K
  • Novus Surgical Consultants$906
  • Medtronic$688
  • Stryker$186
  • Arthrex$154
  • plus $405 from 9 others

What the payments were for

  • Consulting fees$35,47565%
  • Travel & lodging$16,46430%
  • Food & beverage$2,7815%
  • Entertainment$1480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,868 in reported general payments places this provider in the 75th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$121,418
Medicare patients
337
Services billed
998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin231$1,602
Tizanidine Hcl36$333
Methylprednisolone45$234
Celecoxib20$228
Cyclobenzaprine Hcl44$212
Tramadol Hcl90$198
Meloxicam48$164
Oxycodone Hcl28$127
Diclofenac Sodium16$93
Mupirocin12$62
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$39
Cephalexin13$26
Alprazolam17$6

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →